Peter Hofland, PhD has not received any gifts yet
Published today Online at Medscape Internal Medicine, Art Caplan PhD, a Bioethicist at the University of Pennsylvania, Department of Medical Ethics and Health Policy, commented on the question…Continue
According to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting, being held in Atlanta,September 22-25, 2013, early-stage breast cancer patients who receive external beam therapy or XRT are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies.
Various studies have shown that…Continue
Results of a study presented today at the American Society of Radiation Oncology's (ASTRO's) 55th Annual Meeting held in Atlanta, September 22-25, 2013 shows that Sulfasalazine (Azulfidine®, Pfizer), a drug commonly prescribed to reduce diarrhea in patients with rectal bleeding and abdominal pain in patients with ulcerative colitis, a condition in which the bowel is inflamed, does not reduce diarrhea in patients receiving radiation therapy for cancers in the pelvic area. The study…Continue
Breast cancer is the most common cancer among women worldwide. According to the American Cancer Society (ACS), approximately 235,000 women in the United States will be diagnosed with breast cancer. Based on long-term data, it is expected that in 2013 40,000 will die from the disease in the U.S. alone. 
Once breast cancer becomes metastatic, it is…Continue
Despite the success of recent approved therapeutics to treat advanced melanoma, metastatic cancer cells inevitably evolve resistance to drugs. In the September 19. 2013 edition of the journal Cell Reports, a team of researchers based at The Wistar Institute in Philadelphia, PA (USA), report on the mechanics by which melanoma can evolve resistance to a powerful combination of drugs — BRAF and MEK…Continue
For more than a century scientists have been searching for noninvasive technologies to peer deep inside the human body by using light. With much interests, healthcare professionals involved in the management of patients with cancer, want to see inside the body because they are interested in understanding the numerous subtle and often invisible changes to the human DNA, proteins, cells, and tissue involved in altering the body's normal biology.
For the first time, a team of…Continue
Tissue-conserving cancer surgery is used increasingly in cancer treatment. It is a highly skilled procedure. One of the main challenges in this type of surgery is the detection of tumor margins which involves time-consuming tissue preparation. The goal of tissue-conserving cancer surgery is to remove as much of the tumour as possible while sparing healthy tissue.
Histopathology, which refers to the examination of a biopsy or surgical specimen by a pathologist, and is based on…Continue
The U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 13 to 0, with one abstention, in favor of recommending accelerated approval of a regimen of pertuzumab (Perjeta®, Genentech/Roche) for neoadjuvant treatment in women with high-risk, HER2-positive early stage breast cancer.
Breast cancer is the most common cancer among women worldwide.…Continue
Tiny particles called nanodiamonds (NDs) are very promising candidates in nanomedicine. Researchers have demonstrating that nanodiamonds offer a significant potential as gene/drug delivery platforms in the treatment of cancer. While the potential of nanodiamond in drug delivery has been demonstrated, fundamental mechanisms, thermodynamics, and kinetics of drug adsorption on nanodiamond are still poorly understood.
In a study, supported by a National Science Foundation CAREER…Continue
Findings presented at the European Respiratory Society (ERS) Annual Congress, being held in Barcelona, Spain (September 7 - 11, 2013), shows that collecting samples of exhaled breath from people at a high risk of lung cancer could be a cheap and non-invasive method of diagnosing the disease, according to new research.
Current tests for lung cancer include blood and urine tests, followed by CT scans and chest…Continue
Natural Killer (NK) cells, a component of our innate immune system, are a type of lymphocyte designed to play a major role in defending our bodies in the host-rejection of both virally infected cells and cancer cells, thus protecting our bodies from harm.
Now, for the first time, scientists at Vetmeduni, the University of Veterinary Medicine, Vienna, Austria, show that NK-cell activity can be influenced by…Continue